Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Number of items: 4.

Noble, Simon I. ORCID: https://orcid.org/0000-0001-5425-2383, Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425, Fitzmaurice, David, Bekkers, Marie-Jet, Baillie, Jessica ORCID: https://orcid.org/0000-0002-4592-7286, Sivell, Stephanie ORCID: https://orcid.org/0000-0003-0253-1860, Canham, Joanna ORCID: https://orcid.org/0000-0003-3482-0990, Smith, Joanna D. ORCID: https://orcid.org/0000-0003-4234-6686, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Cohen, Ander, Cohen, David, Evans, Jessica, Fletcher, Kate, Johnson, Miriam, Maraveyas, Anthony, Prout, Hayley ORCID: https://orcid.org/0000-0003-0170-7027 and Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631 2015. A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT). Health Technology Assessment 19 (83) , pp. 1-94. 10.3310/hta19830
file

Geldart, Thomas, Chester, John ORCID: https://orcid.org/0000-0002-7830-3840, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Crabb, Simon, Elliott, Tony, Protheroe, Andrew, Huddart, Robert A., Mead, Graham, Barber, Jim, Jones, Robert J., Smith, Joanna ORCID: https://orcid.org/0000-0003-4234-6686, Cowles, Robert, Evans, Jessica and Griffiths, Gareth 2015. SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma. European Urology 67 (4) , pp. 599-602. 10.1016/j.eururo.2014.11.003
file

Noble, Simon, Smith, Joanna D., Baillie, Jessica, Baglin, T., Griffiths, Gareth O., Casbard, Angela, Cohen, Deborah, Fitzmaurice, D., Hood, Kerenza, Rose, P., Cohen, A., Johnson, Miriam, Maraveyas, A., Bell, John, Toone, H. and Nelson, Annmarie 2014. ALICAT: Anticoagulation length in cancer associated thrombosis - a mixed-methods feasibility study. Thrombosis Research 133 (Supp 2) , S220-S220. 10.1016/S0049-3848(14)50032-1

Smith, Joanna D. ORCID: https://orcid.org/0000-0003-4234-6686, Baillie, Jessica ORCID: https://orcid.org/0000-0002-4592-7286, Baglin, Trevor, Griffiths, Gareth O., Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Cohen, David, Fitzmaurice, David A., Hood, Kerenza ORCID: https://orcid.org/0000-0002-5268-8631, Rose, Peter, Cohen, Alexander T., Johnson, Miriam, Maraveyas, Anthony, Bell, John, Toone, Harold, Nelson, Annmarie ORCID: https://orcid.org/0000-0002-6075-8425 and Noble, Simon Ian Robert ORCID: https://orcid.org/0000-0001-5425-2383 2014. A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment of Cancer Associated Thrombosis (ALICAT): study protocol for a mixed-methods study. Trials 15 (1) , 122. 10.1186/1745-6215-15-122
file

This list was generated on Thu Dec 8 07:44:39 2022 GMT.